Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from OneSource Specialty Pharma Limited ( (IN:ONESOURCE) ) is now available.
OneSource Specialty Pharma Limited held its 18th Annual General Meeting, the first since its listing, on September 22, 2025, via video conferencing. The meeting was conducted in compliance with relevant regulations, and Bharat Shah was elected as the Chairperson in the absence of the usual chair and other directors. The AGM highlighted the participation of key board members and management, underscoring the company’s commitment to transparency and stakeholder engagement.
More about OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, operates in the pharmaceutical industry. The company focuses on providing specialized pharmaceutical services and products, with a market focus on innovative drug delivery solutions.
Average Trading Volume: 5,125
Technical Sentiment Signal: Hold
Current Market Cap: 210.3B INR
See more data about ONESOURCE stock on TipRanks’ Stock Analysis page.